Stina Gestrelius

Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge, in the absence of itching. Standard treatment consists of antimicrobials, but recurrence rate is15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation’s top ten threats to global health in 2021 and research into novel non-antimicrobial based treatments is timely.

NordForsk is an organisation under the Nordic Council of Ministers that provides funding for and facilitates Nordic cooperation on research and research infrastructure. NordForsk was established in 2005 by the Nordic Council of Ministers for the purpose of strengthening Nordic research. NordForsk’s key stakeholders comprise the national research councils, universities and other research-funding bodies. Together we work to identify common Nordic priorities and provide funding for research and research infrastructure. NordForsk brings together national research groups and promotes research activities of the highest scientific quality. NordForsk seeks to enhance the quality, impact and efficiency of Nordic research cooperation, thereby helping the Nordic region to become a world leader in research and innovation. Arne Flåøyen is the Director of NordForsk.

As part of the Nordic Council of Ministers, Nordic Innovation is a key actor in implementing the Nordic co-operation programme for innovation and business policy. Nordic Innovation contributes to making the Nordic region a pioneering region for sustainable growth by increasing entrepreneurship, innovation and competitiveness. Read more about us, our partners and projects at www.nordicinnovation.org.

The Swedish Research Council has a leading role in developing Swedish research of the highest scientific quality, thereby contributing to the development of society. Besides research funding, the agency advises the government on research-related issues and participates actively in the discussions to create understanding of the long-term benefits of research. ___________________________________________________________________________________ Vetenskapsrådet har en ledande roll för att utveckla svensk forskning av högsta vetenskapliga kvalitet och bidrar därmed till samhällets utveckling. Utöver finansiering av forskning är myndigheten rådgivare till regeringen i forskningsrelaterade frågor och deltar aktivt i debatten för att skapa förståelse för den långsiktiga nyttan av forskningen.

Gedea Biotech developes pHyph to treat and prevent recurrence of bacterial vaginosis. Bacterial vaginosis (BV) is a very common condition with a prevalence of 10-30% for women of childbearing age. The symptoms can very disturbing and include an often profuse thin, white, “fishy” smelling vaginal discharge, in the absence of itching. Standard treatment consists of antimicrobials, but recurrence rate is15–30 % within 3 months. pHyph will treat the infection and prevent recurrence without the use of antmicrobials. Antimicrobial resistance is one of the World Health Organisation’s top ten threats to global health in 2021 and research into novel non-antimicrobial based treatments is timely.